BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers.
Autor: | O'Reilly, Eileen Mary, Bauer, Todd Michael, Borazanci, Erkut Hasan, Pelster, Meredith, Varghese, Anna M., Park, Wungki, Patel, Manish R., Jameson, Gayle S., Larsen, Mary, Chin, Kathryn, Melink, Teresa J., Gutheil, John, Cosgrove, Elizabeth O'Reilly, Balogh, Kristen N., Maiwald, Tim, DeMario, Mark, Celik, Ilhan, Türeci, Özlem, Sahin, Ugur, Wang, Judy S. |
---|---|
Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p654-654, 117p |
Databáze: | Supplemental Index |
Externí odkaz: |